Erratum to 'JAK1 promotes HDV replication and is a potential target for antiviral therapy' [J Hepatol 80 (2024) 220-231]. Heuschkel MJ, Bach C, Meiss-Heydmann L, Gerges E, et al. J Hepatol 2024 Mar 30:S0168-8278(24)00165-X. doi: 10.1016/j.jhep.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Heuschkel MJ, Bach C, Meiss-Heydmann L, Gerges E, et al. Erratum to 'JAK1 promotes HDV replication and is a potential target for antiviral therapy' [J Hepatol 80 (2024) 220-231]. J Hepatol 2024 Mar 30:S0168-8278(24)00165-X. doi: 10.1016/j.jhep.2024.
PMID: 38556411